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Abstract: Cross-regulation of complex biochemical reaction
networks is an essential feature of living systems. In a biomim-
etic spirit, we report on our efforts to program the temporal
activation of an artificial metalloenzyme via cross-regulation
by a natural enzyme. In the presence of urea, urease slowly
releases ammonia that reversibly inhibits an artificial transfer
hydrogenase. Addition of an acid, which acts as fuel, allows to
maintain the system out of equilibrium.
Thanks to numerous attractive features, biocatalysis, relying
on isolated enzymes, has gained increasing attention among
the synthetic chemistry community.[1] To further improve on
this asset, the focus is shifting towards enzyme cascades
whereby an intermediate produced by a first enzyme acts as
the substrate for a second enzyme etc. Such in-series
assembled enzymes (Scheme 1a) allow to circumvent the
time-consuming isolation and purification of intermediates.
However, increasing the complexity of enzyme cascades often
lead to suboptimal material flux as well as to inhibition.[2]
In living systems operating far from equilibrium, bio-
chemical cascades have evolved to include signal transduction
as well as metabolic and allosteric regulation safeguards that
affect both the spatial control of intermediates and the
temporal occurrence of events.[3]
Thanks to the progress in computational systems biology
and genetic engineering, it has become possible to engineer in
vivo synthetic gene networks to control some of the funda-
mental properties of living systems.[4]However, understanding
at the molecular level the details of such complex, off-
equilibrium (bio)chemical reaction networks remains chal-
lenging.[5–8]
In the past decade, artificial metalloenzymes (ArMs) have
attracted increasing attention as alternative to both homoge-
neous catalysts and enzymes.[9] Artificial metalloenzymes
result from the incorporation of an abiotic metal cofactor
within a protein environment. In contrast to homogeneous
catalysts, ArMs can be combined with natural enzymes to
afford enzyme cascades.[10] With the long-term goal of
engineering artificial metabolic pathways,[11] we report on
our efforts to introduce a programmable enzymatic temporal
control of the activity of an artificial metalloenzyme.
In order to program such an off-equilibrium control of the
activity of an ArM, we reasoned that one could combine in
parallel an enzyme that produces a reversible inhibitor of the
ArM (Scheme 1b). Such cross-regulated biochemical net-
works play a key role in living systems (Scheme 1c). With
Scheme 1. Enzyme cascades, a) combined in series and b) in parallel.
c) Phosphofructokinase, a key committed step of glycolysis, is inhib-
ited by citrate (ArM is an artificial metalloenzyme).
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only starting materials present at the onset of the reaction,
both the enzyme and the ArM are active. As the product of
both enzymatic reactions accumulate, the ArM is inactivated
(Scheme 1b). Ideally, upon removal or consumption of the
inhibitor, the activity of the ArM is restored. Building on our
previous experience with artificial transfer hydrogenases
(ATHase hereafter) based on the biotin-avidin technology,[9b]
we set out to program the ATHase activity by combining it
with an enzyme that produces an inhibitor.
In order to conveniently monitor the activity in real-time,
we selected enrofloxacin 1 as an ATHase substrate.[12] The
fluoroquinolone substrate 1 is a versatile antibiotic against
both Gram-positive and Gram-negative bacteria. Upon
reduction of the C=C double bond, the resulting b-ketoacid
spontaneously decarboxylates to afford a yellow product 2
(Figure S1 in the Supporting Information). The carboxylate
group of enrofloxacin 1 is essential for its antibacterial
activity; its loss results in a significant increase of minimal
inhibitory concentration.[13]
We selected an ATHase comprised of a biotinylated
Cp*Ir(4,7-dihydroxy-1,10-phenanthroline) 3 (Cp*= 1,2,3,4,5-
pentamethylcyclopentadienyl) and the streptavidin K121R
variant (Sav K121R) (Scheme 2a). The ATHase [(Biot-
Cp*)Ir(N^N)] 3·Sav K121R was previously reported for its
remarkable ATHase activity for the reduction of imines, using
either NAD(P)H or formate as hydride source in the presence
of a variety of enzymes, sharing a common intermediate (i.e.
in-series enzyme cascades, Scheme 1a).[10c] A preliminary
screen led to the identification of the following reaction
conditions: ATHase (10 mm, 0.5 mol%) enrofloxacin
1 (2 mm), formate (2m) and MOPS (0.1m, pH 7.0). At 37 8C,
96 turnovers (96 TON) were obtained after 8 hours.
Next, the pH-dependence of the [(Biot-Cp*)IrCl(N^N)]
3·Sav K121R activity was evaluated by determining the initial
rate of the reduction of enrofloxacin 1 by monitoring the
appearance of the ketone 2 at 430 nm (Scheme 2b). A bell-
shape pH-profile was observed, both for the free non-
biotinylated cofactor [(Cp*)IrCl(N^N)] 4 as well as the
ATHase [(Biot-Cp*)IrCl(N^N)] 3·Sav K121R. As the
ATHase [(Biot-Cp*)Ir(N^N)] 3·Sav K121R is completely,
but reversibly inhibited at pH > 8.0, we speculated that we
may cross-regulate its activity by coupling it in parallel with
an enzyme that produces a base as reaction product (Sche-
me 1b). To evaluate the stability of the ATHase upon cycling
the pH from pH < 6.0 to pH > 8.5, the reaction mixture was
repeatedly spiked with HCl and NaOH. Monitoring the
absorbance at 430 nm unambiguously demonstrates the
activity of the ArM towards enrofloxacin 1 in acidic
medium. Addition of NaOH causes the ATHase to stall.
Subsequent addition of HCl leads to a 30% erosion of
ATHase activity for the second cycle. Gratifyingly, the activity
for the second to fifth cycles remains constant (Scheme 2c
and Figure S2).
Urease from Canavalia ensiformis (Jack bean, E.C.
3.5.1.5) was selected as alkali-generating enzyme to be
integrated in parallel with the ATHase [(Biot-Cp*)Ir(N^N)]
3·Sav K121R. Urea rapidly reacts with urease to afford carbon
dioxide and two equivalents of ammonia. Addition of
bromothymol blue allows to conveniently monitor the pH
profile (i.e. reflecting the urease activity) by relying on the
absorption ratio at 618 nm/501 nm (absorption maximum and
isosbestic point, respectively) (Figure S3). In the presence of
either [(Cp*)IrCl(N^N)] 4 or [(Biot-Cp*)IrCl(N^N)] 3, no
pH variation could be observed upon addition of urease and
urea (Scheme S1). We conclude that either organometallic
catalyst [(Cp*)IrCl(N^N)] 4 or bare cofactor [(Biot-
Cp*)IrN^N] 3 inactivates the urease. In the presence of
both the ATHase [(Biot-Cp*)IrN^N] 3·Sav K121R and
urease, the pH gradually increases upon addition of urea,
Scheme 2. a) Structure of the biotinylated iridium complex 3 and
schematic representation of the corresponding artificial transfer hydro-
genase (ATHase) tested for the reduction of enrofloxacin 1 using
formate as hydride source. b) pH-dependence of enrofloxacin 1 reduc-
tion by ATHase [(Biot-Cp*)Ir(N^N)] 3·Sav K121R (solid line) and by
[(Biot-Cp*)Ir(N^N)] 4 (dashed line). c) Activity profile resulting from
pH cycling upon addition of HCl and NaOH (see also Figure S2).
Reaction conditions: 10 mm ATHase [(Biot-Cp*)Ir(N^N)] 3·Sav K121R
(or complex 4), 1 mm enrofloxacin 1, and 2m HCOONa in 10 mm
buffer at 37 8C.
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highlighting the compatibility of both ATHase and urease
partners (Scheme S2).
Next, the activity of ATHase [(Biot-Cp*)Ir(N^N)] 3·Sav
K121R was evaluated in the presence of urease and urea. The
initial pH was set to pH 9.0, where both urease and ATHase
are inactive. Upon lowering the pH to 5.0 by addition of
HClaq, both the ATHase and the urease are activated as
reflected by the appearance of product 2 and the slow
increase in pH. The ATHase remains active until pH 8 at
which point, it is inhibited by the product of urease: ammonia
(Scheme 3b). Addition of HClaq, restores 86% of the initial
ATHaseQs activity, highlighting the reversible inhibition of the
ATHase (Scheme 3c). As can be appreciated, the activity of
the ATHase (as revealed by the increase in absorbance at
430 nm) correlates with the pH variation (monitored by the
ratio of absorbance at 618 nm/501 nm in the presence of
bromothymol blue as pH indicator) (Scheme 3c, Figure S4
and Scheme S4). In the presence of urease, the ATHase stalls
below pH 7.0, instead of pH > 8.0 for the isolated ATHase
(Scheme 2b). We speculate that this arises from the formation
of ammonia from urea which competes with formate as
a ligand for the Ir-center thus leading to an earlier onset of
(reversible) inhibition. Upon fine-tuning the concentrations
of urea and the urease, the activity window of the ATHase can
be time-programmed (Scheme 3b).
Enzymatic logic gates producing a pH change as output
have been reported. In such systems, urease and esterase are
used to produce base and acid, respectively.[14] Building upon
this, we hypothesized that one could use a dormant activator
to substitute HCl, and thus program the progressive onset of
Scheme 3. a) Schematic representation of the pH-dependent activation
of ATHase [(Biot-Cp*)Ir(N^N)] 3·Sav K121R and urease. b) Time-
dependent reduction of enrofloxacin 1 by the ATHase in the presence
of urease and urea. The reaction was monitored at 430 nm (see
Figure S1). c) (Re)activation of the ATHase (blue trace) and urease by
addition of acid (orange trace). Experimental conditions; 25 mm
ATHase [(Biot-Cp*)Ir(N^N)] 3·Sav K121R, 1 mm enrofloxacin 1, 0.1–
0.4 mgmL@1 urease, 150–300 mm urea and 2m HCOONa in 10 mm
CHES (pH 9.0) at 37 8C. An aliquot of 5m HCl (3.2 mL and 5 mL for 1st
and 2nd addition, respectively to bring the pH down to 5.0) was added
per 200 mL of the reaction mixture (see also Scheme S3).
Scheme 4. a) Schematic representation of time-dependent reduction of
enrofloxacin 1 by ATHase [(Biot-Cp*)Ir(N^N)] 3·Sav K121R pro-
grammed by esterase activation and urease inhibition. b) Time depen-
dent reduction of enrofloxacin 1 in the presence of ATHase, urease
and esterase (solid line), ATHase and esterase (dashed line) and
ATHase and urease (dotted line). Experimental conditions: 25 mm
ATHase [(Biot-Cp*)Ir(N^N)] 3·Sav K121R, 1 mm enrofloxacin 2,
0.2 mgmL@1 urease, 150 mm Urea, 0.5 mgmL@1 esterase, 80 mm ethyl
butyrate and 2m HCOONa in 10 mm CHES (pHinitial=9.0) at 37 8C.
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ATHase activity. We evaluated the performance of the
ATHase [(Biot-Cp*)Ir(N^N)] 3·Sav K121R in the presence
of urease, that produces the alkali inhibitor and the esterase
from porcine liver (E.C. 3.1.1.1) and its substrate ethyl
butyrate, the dormant activator (Scheme 4). Upon addition of
ethylbutyrate to a solution containing urea (the dormant
deactivator), enrofloxacin 1, the ATHase, urease and the
esterase, a slow onset of ATHase activity was observed as well
as a slow inhibition resulting from the production of
ammonia. In the absence of esterase, no product 2 could be
detected.
In summary, we have demonstrated the temporal control
of an ATHase upon combining it in-parallel with an enzyme
that slowly releases an inhibitor as a response to an external
stimulus. The reaction network is maintained off-equilibrium
by addition of acid which acts as an activator to fuel the
reaction. Upon stalling, neutralization of the inhibitor by
addition of a fast activator allows to restore enzymatic
activity. Accordingly, the operational time-window of the
ATHase can be programmed at will. This self-regulating, off-
equilibrium feature is orchestrated by a feedback mechanism
reminiscent of complex cellular networks (Scheme 1c). We
anticipate that the concept of temporal catalyst activation will
contribute to engineer complex, bottom-up (bio)chemical
reaction networks that combine both natural and artificial
enzymes. In particular, the prospect of exploiting a pH switch,
may allow to specifically turn on the ATHase activity in
cancer cells where the pH is lower than in healthy cells.
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